{
    "componentChunkName": "component---src-templates-blog-post-js",
    "path": "/posts/45918702516511eca43e95ba21fc3283/",
    "result": {"data":{"allMysqlLists":{"edges":[{"node":{"title":"Victoria records 918 new COVID cases, mRNA vaccine trials to begin in 2022","status":1,"alt":"Shoppers both seated and walking in a Melbourne arcade with a Christmas tree in the background.","src":"https://live-production.wcms.abc-cdn.net.au/e1c5b7abcf23745f6dc72993a9d7b651","source":"abc","menu":"au","local_src":"","load_img":"","img_url":"https://live-production.wcms.abc-cdn.net.au/e1c5b7abcf23745f6dc72993a9d7b651","href":"https://www.abc.net.au/news/2021-11-30/victoria-records-new-covid-cases-deaths/100660460","description":"There are now 11,417 active COVID cases in the state and 512 people have died during the current Delta outbreak.","country":"au","create_time":"2021-11-29T22:40:13.000Z","content":"[\"Victoria has recorded 918\\u00a0new COVID-19 cases and six\\u00a0deaths.\", \"There are now 11,417\\u00a0active COVID cases in the state and 512\\u00a0people have died during the current Delta outbreak.\", \"The new cases were identified from 45,658\\u00a0test results.\", \"There are 305\\u00a0COVID-19 patients in Victorian hospitals, with 41\\u00a0active cases in ICU and 19\\u00a0patients on ventilators.\", \"The Health Department said there were a further 53\\u00a0patients in intensive care whose COVID infections had cleared.\", \"<div class=\\\"head3\\\">Trials for local\\u00a0mRNA vaccine candidate about to begin</div>\", \"An mRNA vaccine candidate developed in Melbourne is about to begin clinical trials, potentially paving the path to Australia's first locally manufactured mRNA vaccine.\", \"The vaccine is being developed by the Monash Institute of Pharmaceutical Sciences, in a project involving the Doherty Institute and manufacturer IDT Australia.\", \"Today the government joined researchers to announce clinical trials would begin in the new year.\", \"Researchers previously said the trials would run for a year, but early results could indicate the vaccine's effectiveness after the first three months.\", \"The vaccine differs to the current Pfizer mRNA vaccine by presenting a more specific part of the spike protein to the body in a bid to trigger a more effective immune response to variants such as Delta or Omicron.\"]","href_hash":"45918702516511eca43e95ba21fc3283"}}]}},"pageContext":{"slug":"45918702516511eca43e95ba21fc3283"}},
    "staticQueryHashes": ["3649515864","764694655"]}